DERMA SCIENCES, INC. 4
4 · DERMA SCIENCES, INC. · Filed Mar 4, 2016
Insider Transaction Report
Form 4
COLE ROBERT C
Executive VP - Sales
Transactions
- Award
Common Stock
2016-03-02+3,100→ 72,472 total - Award
Stock Option (right to buy)
2016-03-02+12,000→ 12,000 totalExercise: $3.30From: 2016-03-02Exp: 2026-03-02→ Common Stock (12,000 underlying) - Tax Payment
Common Stock
2016-03-02$3.30/sh−1,136$3,749→ 71,336 total - Award
Stock Option (right to buy)
2016-03-02+10,400→ 10,400 totalExercise: $8.83From: 2016-03-02Exp: 2025-02-12→ Common Stock (10,400 underlying)
Footnotes (4)
- [F1]The shares of common stock reported herein represent restricted stock units issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on February 12, 2015, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2015, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2015 were met, resulting in the vesting of 3,100 restricted stock units.
- [F2]Shares withheld in connection with the vesting of 3,100 restricted stock units, previously granted pursuant to the issuer's equity incentive plan, at a closing price of $3.30, as reported herein.
- [F3]The options reported herein were issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on February 12, 2015, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2015, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2015 were met, resulting in the vesting of 10,400 options.
- [F4]The options, granted pursuant to the issuer's equity incentive plan, vested as to 25% on the grant date and will vest as to an additional 25% on March 2 of 2017, 2018 and 2019.